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Abstract 
 
Mammalian primordial germ cells (PGCs) are specified in the early post-implantation embryo. 
Attempts have been made to establish in vitro PGC development since the derivation of 
embryonic stem cells (ESCs) from blastocysts. Despite the advances made with mouse 
models, similar studies in human germ cell development have not progressed because 
practical and ethical reasons prevent the use of early human embryos. Recently, we and 
others developed a robust in vitro system for producing human primordial germ cell-like cells 
(hPGCLCs) from ESCs and induced pluripotent stem cells (iPSCs) by inducing competency 
for germ cells. Strikingly, the molecular mechanism for germline differentiation is not fully 
conserved between mouse and human, probably because of the differences in their early 
embryogenesis and regulation of the pluripotent state. Here, we present a review of the 
current status in the field of in vitro germ cell production from pluripotent stem cells, and 
discuss how its usefulness could be extended to clinical applications. 
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Introduction 
The fate of human germ cells is determined during weeks 2-3 of embryonic development [1, 
2]. Since early human embryos are not accessible for practical and ethical reasons, most of 
the knowledge of mammalian germ cell development is based on studies of mice. While 
some animals, such as Xenopus laevis, Caenorhabditis elegans and Drosophila 
melanogaster, carry maternal pre-determinants of germ cell fate, the mouse, as well as the 
axolotl and cricket, show specification of PGCs from a subset of competent precursors 
induced by signaling factors that include bone morphogenetic protein (BMP) and Wnt which 
are secreted from surrounding tissues [3-5]. The nascent PGCs express key transcription 
factors, such as BLIMP1, TFAP2C and SOX17 (in human), establishing a molecular network 
for germ cell fate, which also initiates the germline epigenetic program [6]. Following 
gastrulation, PGCs migrate through the hindgut towards the embryonic testes/ovaries, called 
genital ridges or gonads. The specified PGCs then undergo epigenetic resetting which 
includes DNA de-methylation and changes in histone modifications [3, 7]. Finally the PGCs 
undergo sex-specific differentiation and enter meiosis to complete gametogenesis (Figure 1) 
[8]. 
 
The mouse has been the main model organism for studying mammalian early germ cell 
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development. Based on knowledge obtained from in vivo studies, defined and robust 
protocols for inducing PGC-like cells (PGCLCs) in vitro from mouse pluripotent stem cells 
(PSCs) have been established [9, 10]. PSCs are embryonic stem cells (ESCs) derived from 
the inner cell mass (ICM) of blastocysts, or induced pluripotent stem cells (iPSCs) derived 
from somatic cells [11-14]. When introduced back into blastocysts, PSCs have the potential 
to contribute to the germline in vivo. Furthermore, mouse PGCLCs (mPGCLCs) can be 
induced from naïve PSCs through the induction of competent “epiblast-like cells (EpiLCs)”[9]. 
After injecting mPGCLC into mouse testes or ovaries, they can further develop into 
functional sperm or eggs, respectively [9, 10]. Recently, Zhou et al. claimed that their culture 
protocol allows the produce of haploid male germ cells from in vitro mPGCLCs through 
meiosis [15].  
 
Researchers have made various attempts to understand human PGC development. 
Although our current knowledge of PGC development originates from mouse studies, the 
morphology of early human embryos, especially the epiblasts where PGCs are induced, 
differs from the mouse. Extra-embryonic ectoderm (ExE) that develops over the epiblast 
tissue in mice, and is the source of BMP4 that induces PGC fate in mice, is not present in 
human postimplantation embryos [16, 17]. While mouse epiblasts develop as an egg-
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cylinder, human epiblasts develop as a flat bi-laminar disc, a feature that is also observed in 
a number of non-rodent mammals [16].  
 Since early human embryos are not available for research purposes, it would be a 
significant breakthrough to have a robust in vitro human germ cell development model that 
allows the study of the mechanism regulating germ cell fate and epigenetic dynamics. 
Moreover, such as in vitro model could be used for investigating the inheritance of mutated 
epigenetic modifications and mitochondria, causes of infertility, germ cell tumors and other 
related disorders. However, it is not straightforward to directly adopt the mouse in vitro 
PGCLC induction model for similar studies for inducing human germ cells from PSCs, since 
the regulation of pluripotency, including cell morphology and required signaling, differs 
between mouse and human [16, 17]. Attempts to induce germ cells in vitro using 
conventional human PSCs are dependent on their spontaneous differentiation which occurs 
with low efficiency, and the resulting PGC/germ cell-like cells are not well characterized [18, 
19]. 
 
Recently, we and others have reported a robust and defined protocol for inducing human 
PGCLCs (hPGCLCs) from competent hPSCs [20, 21]. The global gene expression profile of 
the hPGCLCs induced using our method is similar to those of in vivo human PGCs and 
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seminoma, a testicular cancer known to have features characteristic of hPGCs. Our 
hPGCLC induction system has allowed the identification of key hPGC specification factors 
and cell surface markers that are crucial for the isolation of hPGCLCs as well as hPGCs and 
seminoma [20]. Interestingly, hPGCLCs induced from both of the two protocols demonstrate 
the characteristics of pre-migratory PGCs that do not develop further under the same culture 
condition [20, 21]. Below, we discuss the current progress of in vitro germ cell development 
from pluripotent stem cells based on the in vivo differentiation, and potential applications of 
this system. 
 
Germ cell development: human versus mouse 
After fertilization, zygotes undergo cleavage divisions and form blastocysts that consist of 
trophectoderm and ICM after 3.5 days. ICM cells develop into primitive endoderm and 
epiblast, which give rise to all the cell lineages of the embryo proper. Importantly, ESCs can 
be derived from ICM cells in vitro, which can self-renew and maintain their pluripotency with 
the potential to differentiate into three germ layers and germ cells. Blastocysts develop into 
post-implantation epiblasts, where PGCs are specified, around week 2 in human, and 
embryonic day (E) 6.5 in mice. Notably, the morphology of the epiblast stage embryos of 
rodents and non-rodents, including those of humans and pigs, is clearly different [16, 22]. 
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Rodents have cup-shaped epiblasts with ExE on top. ExE secrets BMP4, a critical factor for 
inducing PGCs in the subpopulation of epiblast cells in the proximal posterior region [3, 23]. 
Wnt signaling from the posterior primitive endoderm is also important for PGC specification 
[24, 25]. Human epiblasts on the other hand, are disc-like and consist of two layers, an 
epiblast with a primitive endoderm (hypoblast) beneath. Notably, the tissue equivalent to 
ExE in the mouse is not observed in human epiblasts. The bilaminar epiblast seems to be 
more common in mammals such as rabbits and pigs. In the rabbit, specified PGCs 
expressing BLIMP1 can be found in the epiblast during the postimplantation development 
stage when BMP2 and BMP4 are expressed in the surrounding tissue [26]. Expression of 
BMP2 and BMP4 in the equivalent stages of development has also been demonstrated in 
pig embryos [27]. These findings suggest that BMP-signaling seems to be important for PGC 
specification in non-rodent species as well. In mice, nascent PGCs establish the molecular 
network for germline development by expressing the key factors of BLIMP1, TFAP2C and 
PRDM14, while the expression of these factors has not been found in humans [28, 29]. The 
specified PGCs start to migrate in peri-gastrulation embryos around week 4-5 in humans 
and E9.5 in mice and go through the hindgut to reach the genital ridge [2, 3]. At this stage, 
PGCs undergo dynamic epigenetic resetting including global DNA demethylation and 
changes in histone modifications [1, 2, 3, 7, 8, 30]. PGCs in the gonads undergo sex-specific 
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differentiation around week 9-10 in human and E12.5 in mice [2, 8]. Germ cell sex 
determination is largely dependent on interactions with somatic cells in the gonads. Male sex 
determination is marked by the expression of the sex determining region Y (SRY) and the 
SRY-related HMG-box 9 (SOX9) in gonadal somatic cells. Male PGCs enter mitotic arrest 
and remain in G1/G0 until after birth, when the cell cycle, meiosis and spermatogenesis 
resume. On the other hand, female PGCs undergo meiosis through the leptotene, zygotene 
and pachytene stages in the fetal ovaries and get arrested at the diplotene stage of 
prophase I around the time of birth. Female germ cells undergo folliculogenesis, followed by 
the first meiotic division upon hormonal stimulation after birth and the completion of the 
second meiotic division upon fertilization [8]. Retinoic acid (RA) is one of the critical factors 
required for meiotic entry in both female and male germ cells. RA induces meiotic entry in 
the embryonic ovary; however, it is degraded by Cyp26b1 in the embryonic testis in order to 
prevent the mitosis/meiosis transition during development, since male germ cells undergo 
meiosis only after birth [31].  
 
Induction of human germ cell fate from pluripotent stem cells 
Previous attempts to induce human germ cell fate were based on spontaneous 
differentiation using conventional hPSCs. They demonstrated expression of some germ cell 
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markers such as VASA and DAZL. However, global gene expression profiling and further 
characterization were not performed due to the low efficiency of the induction [32-34]. 
Recently, we and others established an efficient and defined protocol for in vitro human 
PGCLC induction from pluripotent stem cells [20, 21]. Taking into account the step-wise 
induction of mouse PGCLCs, it was important to first establish the “competent state” in 
human PSCs as a crucial step towards efficient hPGCLC induction [9, 20, 21]. In our system, 
when human PSCs are cultured with 4 inhibitors (4i) of GSK3b, MEK, p38 and JNK, they 
exhibit increased competency for germ cell fate [20]. The 4i state can be maintained and 
reversed to the conventional state in PSCs. Approximately 10-50% of 4i hPSCs can be 
specified as hPGCLCs in the presence of BMP2/4 and the other cytokines by forming small 
cell aggregates, called embryoids. The 3D structure seems to be important for the hPGCLC 
specification event. The cell number in the embryoids increases over 5 days with germ cell-
specific NANOS3-positive cells appearing around day 3 after hPGCLC induction. The 
resulting PGCLCs have a global transcriptome similar to those of in vivo gonadal PGCs and 
seminoma cells. Interestingly, these PGCLCs show the initiation of epigenetic resetting 
which is indicated by increased levels of hydroxymethyl-cytosine together with down-
regulated methyl-cytosine in a global and locus specific manner [1, 20]. Sasaki et al. cultured 
hPSCs in preformulated manufactured feeder-free medium and showed there was PGCLC 
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induction with an efficiency of around 20% after the addition of BMP4 and the other 
cytokines to the cell aggregates [21]. Incipient mesoderm-like cells (iMeLCs) are induced 
from hPSCs in the presence of Activin A and a Wnt-signaling agonist. The hPSCs obtain 
competency toward PGCLC differentiation with up to 60% efficiency between 42 and 48 
hours after iMeLC induction. The resulting PGCLCs show a global gene expression profile 
similar to hPGCLCs induced from 4i hPSCs. Both iMeLCs and 4i hPSCs express 
mesoendodermal markers, which suggests that the competent states are a peri-gastrulation 
epiblast-like state [20, 21]. Importantly, PGCLCs induced using both protocols do not 
express later gonadal PGC markers such as DDX4 and DAZL, even after prolonged culture, 
suggesting that early human PGC specification and the ensuing development require distinct 
signaling pathways and environments as is also the case for the mouse (see below). 
 
Molecular mechanism of human PGC specification 
Global analysis of the commonly expressed genes of the three human germ cell related cells, 
hPGCLCs, gonadal PGCs and seminoma, has shown there is a unique gene expression 
pattern compared to mouse PGCs [1, 20]. One of the SOX family transcriptional factors, 
SOX17, rather than SOX2 in the case of the mouse, has been found to be expressed in 
human PGCs/PGCLCs/seminoma, while BLIMP1 is expressed as a conserved gene in both 
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human and mouse PGCs. In addition to SOX17, SOX15 is expressed in human PGCLCs 
and PGCs [21, 30]. Moreover, some other genes such as KLF4, TEAD4 and GATA4 are 
uniquely expressed in human PGCs, but not in the mouse counterpart. Conversely, the 
pluripotency gene ESRRB seems to be more dominantly expressed in mouse than in human 
PGCs [1, 20]. During mouse PGC development, the mesodermal gene T is expressed in 
PGC competent epiblast cells and is important for the induction of BLIMP1 and PRDM14 in 
mouse PGCs [25]. Expression of T is observed at a low level in competent human 4iPSCs 
and it increases in the whole cell aggregates after 24 hours of PGCLC induction. 
Interestingly, T expression is lower in PGCLCs than in the surrounding cells [20]. This 
suggests that human PGCLCs are specified in mesodermal-type cells, which are 
subsequently repressed after hPGCLC specification [20]. SOX17 is found to be one of the 
earliest genes expressed in a subset of the cells scattered in the cell aggregates. This marks 
the initiation of PGCLCs, and is followed by BLIMP1 expression in most of these cells that 
also become NANOS3 positive PGCLCs. Notably, while loss of SOX17 abolishes hPGCLC 
differentiation, loss of BLIMP1 induces mutant nascent PGCLCs that show up-regulation of 
somatic genes including endodermal markers, which might be induced by SOX17 [20]. This 
suggests that although SOX17 is important for the endodermal lineage, the combination of 
SOX17 and BLIMP1 is the key intrinsic driver for human PGC specification. The temporal 
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and spatial regulation of cell fate determination by SOX17 and BLIMP1 would be of great 
interest to investigate. BLIMP1, TFAP2C and PRDM14 are known to be the key PGC 
specifiers in the mouse [28, 29]. While BLIMP1 and TFAP2C expression are present during 
human PGCLC differentiation, PRDM14 expression is not detected in day 1 and day 2 
hPGCLCs [20], suggesting that PRDM14 is not involved in early human PGC specification 
unlike mouse but seems important for later events such as epigenetic resetting. Sugawa et 
al. reported that the knock down of PRDM14 doesn’t affect their hPGCLC induction [35]. The 
other pluripotency genes OCT4 and NANOG are expressed in 〜75% and 〜35% of nascent 
PGCLCs, respectively [20]. Thereafter, almost all the specified PGCLCs become positive for 
OCT4 and NANOG. The pluripotency genes, which are expressed in the competent 
precursors, diminish in expression in the nascent PGCs but their expression is restored in 
specified PGCs, similar to in the mouse [3]. Since PGCs are one of the unique cell types that 
express pluripotency genes, it is interesting to investigate how pluripotency genes are 
involved in epigenetic programing in the PGCs for the next generation. Interestingly, while 
the naïve markers TFCP2L1 and KLF4 are expressed in hPGCs/PGCLCs in addition to 
human ICM and reset hPSCs, KLF17 seems to be specific to ICM and reset cells [1, 36-38]. 
The in vitro human PGCLC differentiation system demonstrates that BMP2/4 signaling is 
critical for PGC specification, similar to in the mouse. It most likely activates the downstream 
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SMAD1/5/8 signaling pathway. This suggests that the same signaling pathways establish 
different molecular networks in human and mouse germ cell lineage. It might be related to 
fundamental differences in early embryogenesis and/or the epigenetic setup in the 
competent germ cell precursors of human and mouse PGCs. 
 
 
Isolation of human PGCs 
It is very important to be able to purify and separate the PGC/PGCLC population from the 
tissue or heterogeneous cell culture population for downstream applications. We have 
established hESC lines carrying mCherry with a 2A peptide linker tethered to the PGC 
specific marker NANOS3 immediately upstream of the stop codon [20]. Sasaki et al. have 
established hiPSC lines with BLIMP1-2A-tdTomato and TFAP2C-2A-EGFP [21]. These allow 
the isolation of the hPGCLC population from the aggregates after PGCLC induction, based 
on the gene expression. However, since we cannot perform gene editing on the cells in in 
vivo tissue, instead specific cell surface markers can be used for isolating and detecting the 
PGC/PGCLC population from in vivo cells and other in vitro cell lines. We recently identified 
a combination of two cell-surface proteins, tissue-nonspecific alkaline phosphatase (TNAP) 
and CD38, as markers specific to human PGC [20]. TNAP is a classical and conserved 
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marker of PGCs [39, 40]. Although TNAP is expressed in hPSCs, it becomes hPGCLC-
specific in differentiated aggregates on day 4. CD38 expression, on the other hand, can be 
detected in hPGCs and NANOS3-positive PGCLCs, but not at earlier stages. In contrast to 
embryonal carcinoma (EC) and hPSCs, seminomas express CD38 rather than CD30 [41]. It 
would be of great interest to investigate the respective relationships of CD30/SOX2 and 
CD38/SOX17 in EC/ESC and PGC/seminoma [42]. KIT is also expressed in hPGCs and can 
be used as a specific marker of PGCs in combination with TNAP [1, 32]. While KIT is 
expressed in PGCLCs, it is undetectable at the cell surface. This is most likely due to the 
presence of stem cell factor (SCF) in the PGCLC induction medium, which induces the 
internalization of the ligand, KIT [43, 44]. Finally, other cell surface markers, such as EpCAM, 
INTEGRINa6, and INTEGRINb3, can also be used to isolate PGCLCs [1, 20, 21, 32]. 
 
Maturation of in vitro-induced PGCs 
The currently defined protocols for PGCLC induction from pluripotent stem cells provoke 
early PGC specification and the resulting cells halt at a developmental stage before the 
onset of meiosis and gametogenesis under these culture conditions. While human PGCLCs 
display characteristic features of pre-migratory PGCs, mouse PGCLCs induced with BMPs 
are equivalent to the mouse PGCs at E9.5-12.5 which are migratory-gonadal PGCs (Figure 
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1) [9, 10, 15, 20, 21]. Importantly, these mouse PGCLCs are able to develop further and 
differentiate into functional gametes following injection into mouse tissues [9, 10]. Purified 
male PGCLCs undergo spermatogenesis 10 weeks after injection into seminiferous tubules 
of neonatal mice. The spermatozoa developed from PGCLCs can be used for fertilization by 
intracytoplasmic sperm injection (ICSI) and give rise to healthy offspring by transfer of the 
resulting embryos into a foster mother. The efficiency of mouse PGCLC maturation and 
function seems to be comparable to the same procedure using in vivo PGCs [9]. For females, 
PGCLCs are isolated and reconstituted with female gonadal somatic cells from E12.5 to 
form aggregates [10, 45]. PGCLCs in the aggregates start to express late PGC markers 
DDX4 and DAZL after 3-6 days, as well as the meiotic markers SYCP3 and Stra8 after day 9. 
Day 3-4 aggregates show X chromosome reactivation and imprinting erasure. The 
aggregates can be transplanted into the ovarian bursa of adult immunodeficient mice where 
they undergo oogenesis to form follicles. However, the PGCLC-reconstituted ovaries show 
instability in cumulus cell-oocyte complex formation, and the germinal vesicle stage oocytes 
from PGCLCs exhibit increased frequency of cytoskeletal immaturity and/or fragility [10]. 
PGCLC-derived oocytes can undergo in vitro maturation followed by in vitro fertilization, and 
develop into two-cell embryos with an efficiency comparable to that of in vivo oocytes. 
Around 40% of the two-cell embryos from PGCLCs further develop into blastocysts in vitro. 
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Half of the PGCLC-derived zygotes formed by in vitro fertilization (IVF) produce three 
pronuclei at the pronuclear stage, which is abnormal. Embryos transferred to foster mothers 
gave newborn pups from the PGCLC-derived two-cell embryos at an efficiency of around 4%, 
and the offspring displayed a normal imprinting pattern and was fully fertile [10].  
 
Recently, Zhou et al. demonstrated a method to induce meiosis in vitro using mouse male 
PGCLCs [15]. They optimized the mouse PGCLC induction protocol published by Hayashi et 
al., and obtained PGCLCs differentiated to a stage equivalent to mouse E12.5. Male 
PGCLCs were mixed with early postnatal (day 2 to 8) testicular somatic cells that support 
further male germ cell development. The mixed cells were then cultured in the presence of 
retinoic acid, BMPs and ActivinA for 6 days and started to express later germ cell markers 
such as Ddx4, Stra8 and Dmc1, whose expression is normally found in spermatocytes. On 
the other hand, the earlier markers Blimp1 and Stella were down-regulated at this stage. On 
day 7, the protocol dictates a switch from cytokines to sex hormones, follicle-stimulating 
hormone, testosterone and bovine pituitary extract. The meiotic marker, Prm1 started to be 
expressed after 10 days of culture. In addition to Prm1, expression of haploid spermatid 
markers such as Tp1, acrosin and haprin were observed from day 14. In agreement with this, 
around 14-20% of the cells showed haploid (1C) DNA content. The spermatid-like cells 
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exhibited male-specific imprinting patterns on H19 and Snrpn loci. Spermatid-like cells were 
fertilized by ICSI and about 90% of the injected zygotes developed to the two-cell stage after 
activation. Despite the low number of examples, 2-5% of the embryos that were fertilized 
with spermatid-like cells were born and developed normally to adulthood, while the birth rate 
following ICSI with round spermatids isolated from normal testes is 9.5%. The resulting mice, 
which developed from in vitro spermatid-like cells, were capable of producing offspring [15]. 
While the report of Zhou et al. is interesting, it needs further statistical support to establish 
the validity of its results.  
 
Perspectives and applications of in vitro human germ cell development 
Although efficient in vitro human PGC specification methods have been established, 
currently there is no available protocol to induce further development of nascent hPGCLCs, 
especially in a defined and robust manner. While mouse studies have proposed some 
methods for advanced in vitro PGCLC development, the fundamental differences in 
molecular mechanisms between mouse and human PGC development and the lack of 
access to human early embryos make this research rather challenging. Furthermore, in vitro-
derived human PGCLCs exhibit features slightly earlier than in in vitro-induced mouse 
PGCLCs. This might be due to differences in the germline competent states of the 
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pluripotent stem cells of mice and humans, each of which depend on different signals [9, 10, 
20, 21]. It is also possible that the timing of each PGC gene activation, epigenetic 
programming and signaling, such as BMPs and Wnts, during early PGC development may 
be fundamentally different between mice and humans, possibly due to differences in their 
epiblast morphologies and the timing of the initiation of gastrulation [16, 17]. Interestingly, 
early human embryogenesis is more similar to non-rodent mammals such as pigs and 
rabbits, than rodents. It would be of great interest to investigate non-human primate, rabbit 
or pig PGC development as potential models. Currently, one of the most advanced in vitro 
PGC development mouse models is still largely dependent on spontaneous differentiation 
induced by unknown factors from supporting cells, such as gonadal somatic cells, and the 
induction efficiency seems to be both low and variable. It would be worth examining the co-
culturing of human PGCLCs with appropriate gonadal somatic cells, such as primate, pig 
and rabbit cells, to induce their further differentiation. It is also important to identify the key 
factors expressed by gonadal somatic cells that might support further development of human 
PGCs. In order to establish a human germline in vitro model, understanding of the stepwise 
and sexual dimorphic differentiation of the in vivo germline is crucial, and further detailed 
study of the development of human gonadal somatic cells and their dynamic interaction with 
germ cells is required.  
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Development of hPGC derived from hPSCs would be a powerful model for addressing 
molecular mechanisms involved in this cell fate decision and epigenetic dynamics, and the 
disorders that might cause their misregulation. For instance, patient specific iPSCs could be 
used to investigate mutations that might underlie specific diseases. In addition, new gene 
editing techniques, such as the CRISPR-Cas9 system, could facilitate gene manipulation of 
hPSCs to generate specific mutations. The germline is responsible for the transmission of 
genetic and epigenetic information to subsequent generations. Aberrant epigenetic 
modifications including imprinting and mutant mitochondria, and their transmission through 
the germline can cause human diseases such as metabolic disorders, obesity, neuronal 
disorders and cancers [46, 47, 48]. Aberrant information could be induced by environmental 
factors, which may have an enduring impact over many generations, although the 
mechanistic basis for such claims remains unclear. Recently, we found that some single 
copy loci evade germline epigenetic programming, and their predominant expression in the 
brain is apparently associated with neuronal disorders and other diseases such as obesity 
[1].  In vitro models may provide opportunities to elucidate the mechanisms behind their 
escape from reprogramming, which may also be relevant for the inheritance of 
environmentally induced epigenetic transgenerational modifications. 
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An in vitro hPGC developmental model could be used to advance research in many areas, 
for example for elucidating the role of non-coding RNAs, including piRNAs, on regulating 
transposable elements, and for further development towards gametogenesis. The regulation 
of the ‘mitochondrial bottleneck’ and mitochondrial mutations could also be examined in in 
vitro human PGCs, which are implicated in the pathogenesis of late onset disorders. 
Cancers of germ cell origin, such as seminomas and embryonal carcinomas, as well as 
paediatric brain tumours called germinomas, also merit further investigations, which could be 
investigated using in vitro models. Advances the production od in in vitro derived germ cells 
could also potentially lead to the development of gametes from somatic cells via iPSCs. This 
would be a valuable tool for understanding the molecular basis of treatments in germ cell 
diseases and infertility. However, there are ethical issues, which need to be considered 
carefully when considering research on germ cells. 
 
Conclusion 
Human gem cell development in vitro induced from hPSCs would advance many fields of 
research, such as germ cell biology, epigenetic research, reproductive medicine, and cancer 
research, since they would facilitate studies of molecular mechanisms, genetics and 
epigenetics, and potential drug screening using patient specific iPSCs. Numerous attempts 
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have been made to induce mouse and human germ cell development using in vitro 
pluripotent stem cells, ESCs and iPSCs, representing early embryos [18, 19]. In this review, 
we have mainly focused on the most defined and robust in vitro PGCLC production protocols 
for human and mouse. Thus, we have focused on early PGC specification and differentiation 
events with well-defined isolation protocols for PGCLCs. Surprisingly, the protocols and 
molecular mechanisms involved in PGC specification differ between humans and mice. This 
may be because humans and mice already display differences in early embryogenesis, 
especially in the epiblasts where PGCs are specified. The current protocols for human 
PGCLC induction produce germ cells that develop up to the pre-migratory stage. However, 
mouse PGCLCs can also differentiate into the peri-migratory or gonadal stages, and are 
able to become functional gametes that produce offspring with the support of appropriate 
cells or tissues from the mouse testis/ovary (Figure 1). Currently, mouse PGCLC maturation 
seems to require some factors from primary somatic cells inhabiting the testis or ovary. Thus, 
given that the embryology and the molecular mechanisms of PGC development are different 
between human and mouse, applying mouse protocols to humans and other mammals 
requires careful consideration. Although the development in vitro human germ cells would 
lead to broad scientific advances in basic science and clinical research, the ethical issues 
will need careful consideration. 
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Figure legend 
Figure 1. Germ cell development: in vivo versus in vitro 
Comparison of “in vivo” and “in vitro” germ cell development in human and mouse. In vitro 
germ cells are induced from pluripotent stem cells. Mouse in vitro derived-PGCs can 
undergo meiosis in vitro or in mouse tissue, which can produce offspring through 
intracytoplasmic sperm injection (ICSI). On the other hand, human in vitro PGC development 
currently arrests at the stage, presumably equivalent to the pre-migratory PGCs in week 3-4 
embryos. 
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哺乳類の始原生殖細胞は発生初期の着床後の胚において最初期に運命決定される細胞の一つ
である。ヒトでは倫理的な観点から着床直後の初期胚が扱えないため、着床前初期胚である
胚盤胞から樹立される胚性幹細胞（ES 細胞）などの多能性幹細胞を用いて、始原生殖細胞
の発生を試験管内で再構築する試みが進められてきた。最近、我々と他の研究グループはヒ
ト始原生殖細胞様細胞を多能性幹細胞から効率的に誘導する系を確立した。その分化系では、
多能性細胞から生殖細胞分化への反応性を持つ状態を誘導することが重要であった。興味深
いことに、マウスとヒトでは始原生殖細胞発生の分子機構が異なっていた。これは、マウス
とヒトにおける初期発生機構や多能性制御の違いにより説明できる可能性がある。本稿では、
多能性幹細胞からの生殖細胞分化誘導培養系の現状とその臨床応用などの可能性について述
べる。 
